Who owns REVVITY, INC. (PKI)? Elite investor 13F holders
2 tracked elite investors reported holding REVVITY, INC as of 2026-06-30, including Gotham Asset Management, Bridgewater Associates. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Gotham Asset Management | REVVITY INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 7631212.00 USD | 68589.000000 | Shares | reduce | Original filing |
| Bridgewater Associates | REVVITY INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2688153.00 USD | 24161.000000 | Shares | reduce | Original filing |
| Ancora Advisors / Ancora Holdings | REVVITY INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.